1,3,5(10)-Estratrien-3-ol-17-one 雌酚酮
CAS 53-16-7 MFCD00003620
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- {SNA} Bioactive Small Molecules, Cell Biology, E, Pharmacopoeia, Pharmacopoeia A-Z
- {SNA} APIs
- {SNA} APIs & Metabolites, APIs (Active Pharmaceutical Ingredients) & Metabolites, Analytical Standards, Chromatography, EP Standards, EP Standards E - F, Estrone, Pharmaceutical Standards,
- {SNA} Bioactive
- {SNA} Bioactive Small Molecule Alphabetical Index, Cytokines, Growth Factors and Hormones, E, Estrogen, Hormones, Humulus lupulus (Hops), Panax ginseng, Phytochemicals by Plant (Food/Spice/Herb), Steroid Hormones, 生物活性小分子, 细胞信号转导和神经科学, 细胞生物学,
产品应用
- 该品是1号避孕药用的激素类药炔雌醇的中间体。
相关文献及参考
- [2]. de Padua Mansur A, et al. Long-term prospective study of the influence of estrone levels on events in postmenopausal women with or at high risk for coronary artery disease. ScientificWorldJournal. 2012;2012:363595.
- Both, D., et al.: Anal. Profiles Drug Subs., 12, 135 (1983),
- Merck 14 ,3708
- Merck:3708
- Merck:3708 Beilstein:8(3)1171
- Short: II/27C
- Short: III/10b
- [1]. Caupos E, et al. Photodegradation of estrone enhanced by dissolved organic matter under simulated sunlight. Water Res. 2011;45(11):3341-3350.
- [1]. Caupos E, et al. Photodegradation of estrone enhanced by dissolved organic matter under simulated sunlight. Water Res. 2011;45(11):3341-3350.
- [2]. de Padua Mansur A, et al. Long-term prospective study of the influence of estrone levels on events in postmenopausal women with or at high risk for coronary artery disease. ScientificWorldJournal. 2012;2012:363595.
安全信息
GHS Symbol
- P201 Obtain special instructions before use. 使用前获取专门指示。
- P202 Do not handle until all safety precautions have been read and understood. 已阅读并理解所有的安全预防措施之前,切勿操作。
- P260 Do not breathe dust/fume/gas/mist/vapours/spray. 不要吸入粉尘/烟/气体/烟雾/蒸汽/喷雾。
- P261 Avoid breathing dust/fume/gas/mist/vapours/spray. 避免吸入粉尘/烟/气体/烟雾/蒸汽/喷雾。
- P263 Avoid contact during pregnancy/while nursing. 怀孕/哺乳期间避免接触。
- P264 Wash hands thoroughly after handling. 处理后要彻底洗净双手。
- P270 Do not eat, drink or smoke when using this product. 使用本产品时不要吃东西,喝水或吸烟。
- P271 Use only outdoors or in a well-ventilated area.? 只能在室外或通风良好的地方使用。
- P273 Avoid release to the environment. 避免释放到环境中。
- P280 Wear protective gloves/protective clothing/eye protection/face protection. 戴防护手套/防护服/眼睛的保护物/面部保护物。
- P281 Use personal protective equipment as required. 使用所需的个人防护装备。
- P301+P312
- P302+P352
- P304+P312
- P304+P340
- P305+P351+P338
- P308+P313
- P312 Call a POISON CENTER or doctor/physician if you feel unwell. 如果你感觉不适,呼叫解毒中心或医生/医师。
- P314 Get medical advice/attention if you feel unwell. 获取医疗咨询/就医,如果你觉得不舒服
- P322 Specific measures (see …on this label). 具体治疗(见本标签上的)。
- P330 Rinse mouth. 漱口
- P363 Wash contaminated clothing before reuse. 被污染的衣服洗净后方可重新使用。
- P391 Collect spillage. Hazardous to the aquatic environment 收集对水环境有危害的泄漏物。
- P405 Store locked up. 上锁保管。
- P501 Dispose of contents/container to..… 处理内容物/容器.....
- H302 Harmful if swallowed 吞食有害
- H312 Harmful in contact with skin 皮肤接触有害
- H332 Harmful if inhaled 吸入有害
- H350 May cause cancer 可能致癌
- H351 Suspected of causing cancer 怀疑致癌
- H360 May damage fertility or the unborn child 可能对生育能力或未出生婴儿造成伤害
- H361 Suspected of damaging fertility or the unborn child 怀疑对生育能力或未出生婴儿造成伤害
- H362 May cause harm to breast-fed children 可能对母乳喂养的婴儿造成伤害
- H412 Harmfutoaquaticlifewithlonglastingeffects 对水生生物有害并具有长期影响。
- S45 In case of accident or if you feel unwell seek medical advice immediately (show the label where possible) 发生事故时或感觉不适时,立即求医(可能时出示标签);
- S53 Avoid exposure - obtain special instructions before use 避免接触,使用前获得特别指示说明;
- R45 May cause cancer 可能致癌
- R60 May impair fertility 可能降低生殖能力
- R61 May cause harm to the unborn child 可能对未出生的婴儿导致伤害
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Parenteral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1200 ug/kg/W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria
Skin and Appendages - tumors
REFERENCE :
COREAF Comptes Rendus Hebdomadaires des Seances, Academie des Sciences.
(Paris, France) V.1-261, 1835-1965. For publisher information, see CRASEV.
Volume(issue)/page/year: 195,630,1932TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 108 mg/kg/90W-I TOXIC EFFECTS : Tumorigenic - neoplastic by RTECS criteria Blood - lymphoma, including Hodgkin's disease Skin and Appendages - tumors REFERENCE : ZEKBAI Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. Volume(issue)/page/year: 56,482,1949
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Implant SPECIES OBSERVED : Rodent - guinea pig DOSE/DURATION : 640 ug/kg TOXIC EFFECTS : Tumorigenic - equivocal tumorigenic agent by RTECS criteria Reproductive - Tumorigenic effects - uterine tumors REFERENCE : BSBSAS Boletin de la Sociedad de Biologia de Santiago de Chile. (Santiago, Chile) V.1-12, 1943-55. Discontinued. Volume(issue)/
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Implant SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 48 mg/kg TOXIC EFFECTS : Tumorigenic - equivocal tumorigenic agent by RTECS criteria Blood - leukemia Blood - lymphoma, including Hodgkin's disease REFERENCE : YJBMAU Yale Journal of Biology and Medicine. (333 Cedar St., New Haven, CT 06510) V.1- 1928- V
TYPE OF TEST : Sister chromatid exchange TEST SYSTEM : Rodent - hamster Ovary DOSE/DURATION : 10 umol/L REFERENCE : EXPEAM Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- Volume(issue)/page/year: 44,62,1988
TYPE OF TEST : Cytogenetic analysis TEST SYSTEM : Rodent - hamster Ovary DOSE/DURATION : 50 umol/L REFERENCE : TOLED5 Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- Volume(issue)/page/year: 29,201,1985
TYPE OF TEST : Cytogenetic analysis ROUTE OF EXPOSURE : Intraperitoneal TEST SYSTEM : Rodent - rat DOSE/DURATION : 10 mg/kg REFERENCE : CUSCAM Current Science. (Current Science Assoc., Sadashivanagar P.O., Bangalore 560 080, India) V.1- 1932- Volume(issue)/page/year: 50,425,1981
TYPE OF TEST : DNA adduct ROUTE OF EXPOSURE : Oral TEST SYSTEM : Rodent - rat DOSE/DURATION : 870 nmol/kg REFERENCE : CBINA8 Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1969- Volume(issue)/page/year: 23,13,1978
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Implant SPECIES OBSERVED : Human - man DOSE : 1586 ug/kg SEX/DURATION : male 60 day(s) pre-mating TOXIC EFFECTS : Reproductive - Paternal Effects - spermatogenesis (incl. genetic material, sperm morphology, motility, and count
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Im
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - mouse DOSE : 2520 ng/kg SEX/DURATION : female 3 day(s) pre-mating TOXIC EFFECTS : Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE : FESTAS Fertility and Sterility. (American Fertility Soc., 608 13th Ave. S, Birmingham, AL 35282) V.1- 1950- Volume(issue)/page/year: 20,211,1969
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Parenteral SPECIES OBSERVED : Rodent - hamster DOSE : 2 mg/kg SEX/DURATION : female 1 day(s) pre-mating TOXIC EFFECTS : Reproductive - Fertility - other measures of fertility REFERENCE : JRPFA4 Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- Volume(issue)/page/year: 35,612,1973
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Mammal - species unspecified DOSE : 12500 ng/kg SEX/DURATION : female 1 day(s) pre-mating TOXIC EFFECTS : Reproductive - Maternal Effects - uterus, cervix, vagina REFERENCE : TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(i
其他信息
- 下游产品:奥生多龙 --> 雌二醇 --> 16Α,17Α-环氧-3Β,17Β-二羟基雌甾-1,3,5(10)-三烯-3,17-二醋酸酯 --> 炔雌醇 --> 雌三醇
- Sigma Aldrich:53-16-7(sigmaaldrich)
- Acros Organics:雌酮 Estrone, 99+%(53-16-7)
- 所属类别一:生物化学品: 脂类: 固醇及类固醇类
- 比旋光度:158 ° (c=1, dioxane)
- 雌酚酮价格(试剂级):更新日期 产品编号 产品名称 包装 价格 2011/08/23 66003282 雌酮;α-卵胞激素;雌甾酮;雌激素酮 250mg 442元 2011/04/16 E0026 雌酮 Estrone 5G 1050元 2011/04/16 E0026 雌酮 Estrone 1G 290元
- 用途一:是合成医药炔雌醇的中间体
- 上游原料:醋酸异丙酯 --> 二酮 --> 氯酸溶液[浓度≤10%] --> 二溴 --> 2,4,6-三甲基吡啶 --> 环化合物 --> 5-ALPHA-雄烷
- 海关编码:29335995
- 所属类别二:生物化学品: 生化试剂: 激素
- 方法三:由4-雌甾烯-19-醇-3,17-二酮经发酵法氧化而得。
- 用途三:主要用于子宫发育不全、月经失调及更年期障碍等。是合成炔雌醇药物的中间体。可引起恶心、呕吐、头晕等。久用可引起子宫内膜过度增生发生出血。
- 溶于醇、丙酮、二氧六环、苯、氯仿、吡啶及氢氧化碱溶液,微溶于醚和植物油,几乎不溶于水,水中溶解度:0.03 g/L。
- MSDS 信息:1,3,5(10)-Estratrien-3-ol-17-one(53-16-7).msds
- MOL 文件:53-16-7.mol
- 方法二:以醋酸去氢表雄酮为原料,经加成、环氧化、开环、A环脱氢,制得雌甾酮成品。 醋酸去氢表雌酮[次氯酸]→5α-氯雄甾烷-3β, 6β-二醇-17-酮-3-醋酸酯[HgO, I 2 ]→C-19, C-6氧环化合物[NaOH]→5α-氯-6β, 19-环氧-17-酮-3醇[Zn粉]→[铬酸氧化,消除]19-羟基雄甾-4-烯-3,17-二酮[微生物]→雌甾酮成品。
- 用途二:生化研究,雌性激素类药物。
- 参考质量标准一:比旋光度[α] 20 D +158°-+166°;吸光度(A) 0.32-0.36 (0.04‰, 无水乙醇),灰分≤0.1%。
- 参考质量标准二:美国药典1995版629页 指标名称 指标 指标名称 指标 含量(C18H22O2)/% 97.0-103.0/熔点/℃ 约260 比旋度(c=1,二氧杂环己烷) +158°-+161° 干燥失重% ≤0.5
- 方法一:雌甾二酮经溴化氢溴化得二溴化合物,于2,4,6-三甲基吡啶溶液中回流得粗品,后经甲醇或丙酮重结晶精制而得。
- 溶于醇、丙酮、二氧六环、苯、氯仿、吡啶及氢氧化碱溶液,微溶于醚和植物油,几乎不溶于水,水中溶解度:0.04 g/L。
- 用途四:该品是1号避孕药用的激素类药炔雌醇的中间体。
- 图谱信息:雌酚酮(53-16-7)核磁图( 1 HNMR) 雌酚酮(53-16-7)红外图谱(IR2) 雌酚酮(53-16-7)质谱(MS) 雌酚酮(53-16-7)核磁图( 13 CNMR) 雌酚酮(53-16-7)Raman光谱 雌酚酮(53-16-7)红外图谱(IR1)
